1 Swissmedic (Institut suisse des produits thérapeutiques). Compendium suisse des médicaments 2018 [23 avril 2018]. Disponible sur:
http://www.swissmedicinfo.ch.
2 Blau JE, Tella SH, Taylor SI, Rother KI. Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes Metab Res Rev. 2017;33(8).
3 Burke KR, Schumacher CA, Harpe SE. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature. Pharmacotherapy. 2017;37(2):187–94.
4 Furrer C, Lang M, Dullenkopf A, Wiesli P. SGLT-2-Hemmer-assoziierte schwere diabetische Ketoazidose. Swiss Medical Forum. 2016;16(16):375–7.
5 Goldenberg RM, Berard LD, Cheng AY, Gilbert JD, Verma S, Woo VC, et al. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis. Clin Ther. 2016;38(12):2654–64 e1.
6 Meyer EJ, Gabb G, Jesudason D. SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications. Diabetes Care. 2018 Apr;41(4):e47-e49.
7 McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997;244(1):1–14.
8 Taylor SI, Blau JE, Rother KI. SGLT2 Inhibitors May Predispose to Ketoacidosis. J Clin Endocrinol Metab. 2015;100(8):2849– 52.
9 Qiu H, Novikov A, Vallon V. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives. Diabetes Metab Res Rev. 2017;33(5).
10 Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crisis in adult patients with diabetes. Diabetes Care. 2009;32(7):1339.
11 Dizon S, Keely EJ, Malcolm J, Arnaout A. Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It’s Not Just Euglycemic Diabetic Ketoacidosis. Can J Diabetes. 2017;41(5):499-503.
12 WHO-UMC Causality Categories in «The use of the WHO-UMC system for standardised case causality assessment», from
http://www.who.int/medicines/areas/quality_safety/safety_efficacy/. Access date May 2018.